Miglitol For Type 2 Diabetes Mellitus

Overview

The intestinal absorption of starch, disaccharides, and dextrin is slowed down or delayed when Miglitol, an inhibitor of intestinal alpha-glucosidase, is present. With a structure resembling glucose, Miglitol is a derivative of deoxynojirimycin that inhibits alpha-glucosidase activity in the intestinal brush border. This prevents starch and disaccharides from being broken down into absorbable monosaccharides, which delays the absorption of carbohydrates and lessens the rise in blood glucose after meals. In 1996, Miglitol became the second α-glucosidase inhibitor to be licensed for use in clinical practice in the United States, following Acarbose. The present indications concern the maintenance of glycemic control in individuals with type 2 diabetes, either in isolation through food and exercise or in conjunction with insulin or other oral hypoglycemic medications. Miglitol comes in pills weighing 25, 50, and 100 mg and is sold both under generic and brand names. Adults usually start with a dose of 25 mg with each meal (first bite) and then gradually increase to a maximum of 100 mg three times a day. The most frequent gastrointestinal adverse effects of Miglitol include flatulence, diarrhea, stomach bloating, and rash. Miglitol also causes malabsorption. Pneumatosis cystoides intestinalis and rash are examples of severe adverse effects. When Miglitol is taken with other oral hypoglycemic medications, hypoglycemia may result.

What Is Miglitol?

Miglitol inhibits the conversion of complex carbohydrates into glucose. It stops the breakdown of carbohydrates (such as disaccharides, oligosaccharides, and polysaccharides) into monosaccharides that the body can absorb. It is mostly used in type 2 diabetes to provide better glycemic control.

For best results, take Miglitol at the beginning of a meal. Its efficacy is dependent on the quantity of poly and oligosaccharides in the diet. By inhibiting alpha-glucosidase, Miglitol lowers postprandial hyperglycemia and reduces the amount of carbohydrates accessible for digestion. In contrast to other medications in the same family, Miglitol is not metabolized; instead, the kidneys eliminate the unmetabolized substance.

For Patients:

Why Is a Prescription for Miglitol Given?

Miglitol is used to treat type 2 diabetes, a condition in which the body does not use insulin normally and cannot control blood sugar levels. It can be used alone or in combination with other medications. It is especially useful for those whose diabetes cannot be controlled with diet alone. It inhibits the small intestine's ability to break down and absorb table sugar and other complex carbohydrates. After meals, this mechanism causes blood sugar levels to drop (hypoglycemia).

Diabetes and high blood sugar patients may eventually experience major or perhaps fatal side effects, such as heart disease, stroke, kidney issues, nerve damage, and vision issues. Manage diabetes and enhance health by taking medications, changing the lifestyle (diet, exercise, stopping smoking), and monitoring the blood sugar levels regularly. This treatment may also lower the risk of a heart attack, stroke, kidney failure, nerve damage (numbness, cold legs or feet; reduced sexual function in men and women), eye issues (visual abnormalities, including changes or loss of eyesight), and gum disease, among other diabetes-related concerns. The optimal approach to treat diabetes will be discussed with the doctor and other medical professionals.

One can get additional information about the possible uses of this drug by speaking with a doctor or chemist.

How to Utilize Miglitol?

Miglitol is available as an oral tablet. It is often taken with the first bite of food three times a day. Pay close attention to the instructions on the label of the prescription and ask the chemist or doctor to explain anything one does not understand. Consume Miglitol precisely as prescribed. Never take more or less of it, or take it more frequently than the doctor has instructed.

What Further Safety Measures Must One Take?

If one has an allergy to any medications, including Miglitol, let the doctor and chemist know before starting to use it. Inform the physician and chemist about all of the prescription and over-the-counter drugs one takes, including any diabetes medications, digestive enzymes, Digoxin, Propranolol, Ranitidine, and vitamins.

Inform the physician if one now has or has ever had kidney illness, intestinal blockage, inflammatory bowel disease, or chronic intestinal disease. Inform the physician if one is nursing a baby, intends to get pregnant, or is already pregnant. Contact the physician if one becomes pregnant while taking Miglitol.

What Particular Dietary Guidelines Should One Adhere To?

To manage blood sugar, Miglitol is taken in conjunction with a healthy diet and exercise routine. The blood sugar may drop too low if one skips or postpones meals or exercises more than normal (hypoglycemia). The medication will be effective if one follows the doctor's recommended diet and exercise regimen.

How To Proceed if One Overlooks a Dosage?

As soon as one recalls, take the missed dose. Keep in mind that one should only take Miglitol with food. On the other hand, if the next dose is almost here, skip the one missed and stick to the usual dosage plan. Never take two doses to make up for something if one forgets to take.

What Consequences Might Miglitol Have?

When Miglitol is combined with insulin or other diabetes drugs, it may result in an excessive reduction of blood sugar levels. Use glucose products (Insta-Glucose or B-D Glucose tablets) and give the doctor a call if one has any of the following symptoms.

• Unsteadiness.

• Feeling lightheaded or dizzy.

• Sweating agitation or uneasiness.

• Abrupt behavioral or emotional changes, headache, tingling, or numbness around the mouth, weakness.

• Pale complexion, hunger.

• Awkward or jerky motions.

Fruit juice and other products containing complex sugars, such as table sugar, cannot raise blood sugar levels because Miglitol prevents their breakdown. One and the family members must be aware of the distinctions between Miglitol and other diabetes treatments.

In the absence of treatment, hypoglycemia can cause severe symptoms. Make sure those who spend time with one, such as family and friends, are aware that one should receive medical attention right away if one exhibits any of the following symptoms.

• Disorientation.

• Convulsions.

• Unconsciousness.

What Information Should One Know About How To Store and Discard This Medication?

Keep this medication out of children's reach and keep it in the sealed container it came in. Keep it out of the bathroom and at room temperature, away from sources of heat and moisture.

It is important to dispose of unnecessary prescriptions in a specific manner so that children, dogs, and other people cannot ingest them. However, this drug is not something one should flush down the toilet. The best way to get rid of medication is to use a program called medicine take-back. To find out more about take-back initiatives in the area, speak with the chemist or get in touch with the recycling and trash department.

What Are the Precautions to Taken With Miglitol?

If one has an allergy to Miglitol or any other allergies, let the doctor or chemist know before starting to use it. Inactive chemicals in this product have the potential to trigger allergic reactions or other issues. For further information, consult the chemist. Inform the doctor or chemist about all of the medical history before taking this drug, with particular attention to any issues with the kidneys or intestines, including inflammatory bowel disease, blockages, and ulcers.

Too high or too low blood sugar can cause tiredness, dizziness, and blurred vision. Drive, operate machinery, or engage in any other activity requiring alertness or clear vision until one is certain that one can do so safely. While using this medication, avoid drinking too much alcohol as it may raise the risk of low blood sugar. A stressed body (from a fever, infection, injury, or surgery, for example) may make it more difficult to regulate blood sugar. This may necessitate modifying the medication regimen, blood sugar testing procedures, or treatment strategy. Speak with the physician about this.

Notify the dentist or physician about anything one uses before surgery, including over-the-counter, prescription, and herbal remedies. Only when necessary should this medication be taken while pregnant. With the doctor, go over the advantages and disadvantages. Diabetes may arise from pregnancy or become worse. Plan a strategy for controlling the blood sugar during pregnancy with the physician. One diabetes treatment regimen (diet and drugs, including insulin) may be modified by the doctor during the pregnancy.

What Other Details Ought to One Be Aware Of?

Remember to keep all of the doctor's and the laboratory's appointments. It Is important to periodically monitor blood sugar to see how one reacts to Miglitol. To monitor one reaction to Miglitol, the doctor will prescribe specific laboratory tests. Additionally, the doctor will instruct one on how to measure the blood or urine sugar levels at home to monitor how this medication is working for one. Pay close attention to these instructions.

Wearing a diabetic identity bracelet will ensure that, in the event of an emergency, one receives the right care. Do not give the medication to anyone else. If one has any questions concerning filling the prescription, ask the chemist. One must maintain an official record of every medication, including prescription and over-the-counter (OTC).

For Doctors:

Pharmacology:

Significance:

When diet alone is insufficient to control hyperglycemia in patients with non-insulin-dependent diabetes mellitus (NIDDM), this medication may be used as an adjuvant to enhance glycemic control.

Pharmacodynamics:

As an alpha-glucosidase inhibitor taken orally, Miglitol is a derivative of desoxynojirimycin that slows down the breakdown of carbohydrates consumed, lowering the amount of blood glucose that rises after meals. Miglitol lowers glycosylated hemoglobin levels in patients with Type II (non-insulin-dependent) diabetes mellitus as a result of lowering plasma glucose levels. Glycosylated hemoglobin levels, which indicate systemic non-enzymatic protein glycosylation, are dependent on the average blood glucose concentration throughout time. When used with sulfonylureas, the effect of Miglitol on improving glycemic control is additive due to its distinct mechanism of action. Furthermore, Miglitol lessens the effects of sulfonylureas on insulinotropic and weight-increasing factors. Because of its weak inhibitory action against lactase, methitrol is unlikely to cause lactose intolerance when taken at the prescribed dosages.

Mechanism Of Action

Miglitol does not increase insulin secretion as sulfonylureas do. Miglitol's antihyperglycemic effect is caused by a reversible suppression of intestinal a-glucoside hydrolase enzymes that are associated with membranes. In the brush border of the small intestine, membrane-bound intestinal a-glucosidases hydrolyze oligosaccharides and disaccharides to glucose and other monosaccharides. This inhibition of an enzyme causes a delay in the absorption of glucose and a reduction in postprandial hyperglycemia in people with diabetes.

Absorption:

Miglitol's absorption is saturable at high doses; a dose of 25 mg is fully absorbed, whereas a dose of 100 mg is only 50 to 70 % absorbed. There is no proof that Miglitol's systemic absorption enhances its therapeutic benefits.

Volume Of Distribution:

• 0.18 liters per kilogram.

• Binding of Proteins - Miglitol binds to proteins very little (<4.0 %).

Metabolic Process: Neither humans nor any investigated animal species can metabolize Metformin.

Route of Elimination: Neither humans nor any investigated animal species can metabolize Metformin. It is removed as an unaltered medication by renal excretion.

Half-life: Miglitol has a two-hour half-life when eliminated from plasma.

Clearance: Not Available

Hazardousness: Hypoglycemia cannot be caused by an overdose, in contrast to sulfonylureas or insulin. An overdose may cause diarrhea, abdominal pain, and increased flatulence for a brief period. In the unlikely event of an overdose, no significant systemic reactions are anticipated due to the absence of extra-intestinal effects observed with Miglitol.

Conclusion:

When combined with a healthy diet and exercise regimen, Miglitol helps persons with type 2 diabetes manage their high blood sugar levels. Keeping blood sugar levels under control can help avoid kidney damage, blindness, nerve damage, limb loss, and issues with sexual function. Keeping the diabetes under control may also reduce the chance of having a heart attack or stroke. By slowing down the digestion and absorption of carbs from the diet, Miglitol acts in the intestines. This phenomenon mitigates the postprandial elevation of blood glucose.